{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:16:41Z","timestamp":1787242601367,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.anpedi.2009.12.018","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T04:46:43Z","timestamp":1272257203000},"page":"353.e1-353.e26","source":"Crossref","is-referenced-by-count":2,"title":["Conferencia de Consenso sobre bronquiolitis aguda (V): prevenci\u00f3n de la bronquiolitis aguda. Revisi\u00f3n de la evidencia cient\u00edfica"],"prefix":"10.1016","volume":"72","author":[{"given":"J.","family":"Gonz\u00e1lez de Dios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ochoa Sangrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2009.12.018_bib1","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.anpedi.2009.11.020","article-title":"Grupo Revisor y Panel de Expertos de la Conferencia de Consenso del Proyecto aBREVIADo. Recomendaciones de la Conferencia de Consenso sobre Bronquiolitis aguda","volume":"72","author":"Gonz\u00e1lez de Dios","year":"2010","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2009.12.018_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","article-title":"Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13","volume":"171","author":"Sigurs","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anpedi.2009.12.018_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(98)10321-5","article-title":"Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years","volume":"354","author":"Stein","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2009.12.018_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/INF.0b013e3180618c42","article-title":"The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature","volume":"26","author":"Perez-Yarza","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.12.018_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM199501193320301","article-title":"Asthma and wheezing in the first six years of life","volume":"332","author":"Mart\u00ednez","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2009.12.018_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1067\/mai.2003.162","article-title":"Tucson Children's Respiratory Study: 1980 to present","volume":"111","author":"Taussig","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/ajrccm.162.4.9912111","article-title":"A Clinical Index to define risk of asthma in young children with recurrent wheezing","volume":"162","author":"Castro-Rodr\u00edguez","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anpedi.2009.12.018_bib8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2004.09.020","article-title":"Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma","volume":"114","author":"Guilbert","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib9","first-page":"95","article-title":"Phenotype specific treatment of obstructive airways disease in infancy and childhood: new recommendations of the Swiss Paediatric Pulmonology Group","volume":"135","author":"Kuehni","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.anpedi.2009.12.018_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1695-4033(07)70616-1","article-title":"Grupo de trabajo de para el Consenso sobre Tratamiento del Asma Infantil. Consenso sobre tratamiento del asma en pediatr\u00eda","volume":"67","author":"Castillo","year":"2007","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2009.12.018_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1157\/13126564","article-title":"Sibilancias recurrentes en menores de tres a\u00f1os: evidencias y oportunidades","volume":"69","author":"P\u00e9rez-Yarza","year":"2008","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2009.12.018_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4321\/S1139-76322009000100007","article-title":"Tratamiento de las sibilancias recurrentes\/asma en el ni\u00f1o menor de 3 a\u00f1os de edad","volume":"11","author":"\u00dabeda Sansano","year":"2009","journal-title":"Rev Pediatr Aten Primaria"},{"key":"10.1016\/j.anpedi.2009.12.018_bib13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1542\/peds.102.5.1211","article-title":"Prevention of respiratory syncytial virus infections: indications for the use of palivizumab update on the use of RSV-IGIV","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.12.018_bib14","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1542\/peds.112.6.1442","article-title":"Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections","volume":"112","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.12.018_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1695-4033(00)77360-7","article-title":"Recommendations for the prevention of respiratory syncytial virus infections","volume":"52","author":"Carbonell Estrany","year":"2000","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1695-4033(02)77812-0","article-title":"Guidelines for respiratory syncytial virus prophylaxis. An update","volume":"56","author":"Carbonell-Estrany","year":"2002","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1157\/13079818","article-title":"Recommendations for the prevention of respiratory syncytial virus infection","volume":"63","author":"Figueras Aloy","year":"2005","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2009.12.018_bib18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0025-7753(04)74657-6","article-title":"Utilizaci\u00f3n de evaluaciones econ\u00f3micas de intervenciones sanitarias: el caso palivizumab","volume":"123","author":"Puigvent\u00f3s Latorre","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.anpedi.2009.12.018_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1695-4033(02)77804-1","article-title":"Prophylaxis of respiratory syncytial virus infections with palivizumab","volume":"56","author":"Danes Carreras","year":"2002","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1157\/13073228","article-title":"Palivizumab y bronquiolitis: necesidad de aplicar la eficiencia para adecuar la pr\u00e1ctica cl\u00ednica a las pruebas cient\u00edficas","volume":"124","author":"Gonz\u00e1lez de Dios","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.anpedi.2009.12.018_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1157\/13124223","article-title":"Consenso multidisciplinar espa\u00f1ol sobre la profilaxis de la infecci\u00f3n respiratoria pedi\u00e1trica por virus respiratorio sincitial","volume":"69","author":"Figueras Aloy","year":"2008","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2009.12.018_bib22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1542\/peds.106.3.520","article-title":"Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control","volume":"106","author":"Macartney","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.12.018_bib23","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa051378","article-title":"Long-term inhaled corticosteroids in preschool children at high risk for asthma","volume":"354","author":"Guilbert","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2009.12.018_bib24","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa054692","article-title":"Intermittent inhaled corticosteroids in infants with episodic wheezing","volume":"354","author":"Bisgaard","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2009.12.018_bib25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(06)69285-4","article-title":"Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy IN-fants (IFWIN): Double-blind, randomised, controlled study","volume":"368","author":"Murray","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2009.12.018_bib26","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1183\/09031936.00002108","article-title":"Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach","volume":"32","author":"Brand","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anpedi.2009.12.018_bib27","doi-asserted-by":"crossref","first-page":"b897","DOI":"10.1136\/bmj.b897","article-title":"The effect of high dose inhaled corticosteroids on wheeze in infants alter respiratory syncytial virus infection: randomised double blind placebo controlled trial","volume":"338","author":"Ermers","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2009.12.018_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-3476(98)70316-6","article-title":"Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing","volume":"132","author":"Richter","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/adc.82.2.126","article-title":"Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis","volume":"82","author":"Cade","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpedi.2009.12.018_bib30","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1080\/08035250510028407","article-title":"Dexamethasone inhalations in RSV bronchiolitis: a double-blind, placebo-controlled study","volume":"94","author":"Bentur","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib31","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/adc.63.12.1428","article-title":"Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis","volume":"63","author":"Carlsen","year":"1988","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpedi.2009.12.018_bib32","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archpedi.1996.02170300066013","article-title":"Anti-inflammatory therapy reduces wheezing after bronchiolitis","volume":"150","author":"Reijonen","year":"1996","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.anpedi.2009.12.018_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/adc.80.4.343","article-title":"Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing","volume":"80","author":"Fox","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpedi.2009.12.018_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1034\/j.1399-3038.2000.00068.x","article-title":"Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma","volume":"11","author":"Kajosaari","year":"2000","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib35","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1034\/j.1399-3003.2000.15b27.x","article-title":"No objective benefit from steroids inhaled via a spacer in infants recovering from bronchiolitis","volume":"15","author":"Wong","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anpedi.2009.12.018_bib36","first-page":"351","article-title":"Inhaled corticosteroids and wheezing post-bronchiolitis","volume":"52","author":"Callen Blecua","year":"2000","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib37","first-page":"CD004881","article-title":"Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing","author":"Blom","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.12.018_bib38","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1542\/peds.2008-2867","article-title":"Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis","volume":"123","author":"Castro-Rodr\u00edguez","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.12.018_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/(SICI)1099-0496(199809)26:3<162::AID-PPUL2>3.0.CO;2-N","article-title":"Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up","volume":"26","author":"Berger","year":"1998","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/1099-0496(200008)30:2<92::AID-PPUL3>3.0.CO;2-X","article-title":"Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus","volume":"30","author":"Van Woensel","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib41","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1440-1754.2003.00212.x","article-title":"Long and short-term effect of prednisolone in hospitalized infants with acute bronchiolitis","volume":"39","author":"Zhang","year":"2003","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.anpedi.2009.12.018_bib42","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1542\/peds.104.6.e77","article-title":"Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants","volume":"104","author":"B\u00fclow","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.12.018_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1164\/rccm.200207-747OC","article-title":"A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis","volume":"167","author":"Bisgaard","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anpedi.2009.12.018_bib44","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1164\/rccm.200706-910OC","article-title":"Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children","volume":"178","author":"Bisgaard","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anpedi.2009.12.018_bib45","first-page":"CD002997","article-title":"Macrolides for chronic asthma","volume":"20","author":"Richeldi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.12.018_bib46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1081-1206(10)60935-0","article-title":"Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: A double-blind, randomized, placebo-controlled trial","volume":"97","author":"M\u00f3nica Fonseca","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib47","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2009.12.018_bib48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-3476(98)70056-3","article-title":"Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease","volume":"133","author":"Simoes","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1542\/peds.99.1.93","article-title":"Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis","volume":"99","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.12.018_bib50","first-page":"CD001725","article-title":"Immunoglobulin for preventing respiratory syncytial virus infection","author":"Wang","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpedi.2009.12.018_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.12.018_bib52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0022-3476(95)70547-3","article-title":"Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection","volume":"126","author":"Wang","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/317655","article-title":"Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979\u20131997","volume":"183","author":"Shay","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2009.12.018_bib54","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/bmj.328.7447.1026","article-title":"Prevention of respiratory syncytial virus infection in infants","volume":"328","author":"Handforth","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2009.12.018_bib55","doi-asserted-by":"crossref","first-page":"F64","DOI":"10.1136\/adc.2003.029710","article-title":"Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis","volume":"90","author":"Heikkinen","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.anpedi.2009.12.018_bib56","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1542\/peds.108.4.1000","article-title":"Uncertainty in the management of viral lower respiratory tract disease","volume":"108","author":"Meissner","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.12.018_bib57","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1157\/13073228","article-title":"Palivizumab and bronchiolitis: need to apply the efficiency in order to join clinical practice to scientific studies","volume":"124","author":"Gonz\u00e1lez de Dios","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.anpedi.2009.12.018_bib58","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ppul.20751","article-title":"Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis","volume":"43","author":"Giebels","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ppul.20503","article-title":"Palivizumab efficacy in preterm infants with gestational age < or=30 weeks without bronchopulmonary dysplasia","volume":"42","author":"Grimaldi","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib61","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/ppul.20507","article-title":"Beyond randomized controlled trials: a \u201creal life\u201d experience of respiratory syncytial virus infection prevention in infancy with and without palivizumab","volume":"41","author":"Mitchell","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib62","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/01.inf.0000086403.50417.7c","article-title":"Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants","volume":"22","author":"Pedraz","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.12.018_bib63","doi-asserted-by":"crossref","first-page":"34, e1","DOI":"10.1016\/j.jpeds.2007.02.032","article-title":"Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing","volume":"151","author":"Simoes","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib64","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.inf.0000069768.34383.18","article-title":"Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants","volume":"22","author":"Singleton","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.12.018_bib65","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/01.inf.0000245104.26996.57","article-title":"Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season","volume":"25","author":"Singleton","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.12.018_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.inf.0000105106.93562.d3","article-title":"Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002","volume":"23","author":"Henckel","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.12.018_bib67","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00002018-200326040-00005","article-title":"Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection","volume":"26","author":"Lacaze-Masmonteil","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.anpedi.2009.12.018_bib68","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ppul.10288","article-title":"Palivizumab prophylaxis of respiratory syncytial virus disease in 2000\u20132001: results from The Palivizumab Outcomes Registry","volume":"35","author":"Parnes","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10096-005-0082-y","article-title":"Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29\u201332 weeks","volume":"25","author":"Resch","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.anpedi.2009.12.018_bib70","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1017\/S104795110700042X","article-title":"Respiratory infection in congenital cardiac disease. Hospitalizations in young children in Spain during 2004 and 2005: the CIVIC Epidemiologic Study","volume":"17","author":"Medrano","year":"2007","journal-title":"Cardiol Young"},{"key":"10.1016\/j.anpedi.2009.12.018_bib71","article-title":"Human respiratory syncytial virus and other viral infections in infants receiving palivizumab","author":"Boivin","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib72","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00246-007-9039-5","article-title":"Palivizumab use in subjects with congenital heart disease: Results from the 2000\u20132004 Palivizumab Outcomes Registry","volume":"29","author":"Cohen","year":"2008","journal-title":"Pediatric Cardiology"},{"key":"10.1016\/j.anpedi.2009.12.018_bib73","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1695-4033(02)77805-3","article-title":"Quimioprofilaxis con palivizumab en Andaluc\u00eda. Resultados de la epidemia de VRS 2000\u20132001","volume":"56","year":"2002","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib74","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1651-2227.2004.tb02631.x","article-title":"Appropriate prophylaxis with restrictive palivizumab regimen in preterm children in Sweden","volume":"93","author":"Naver","year":"2004","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib75","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00006454-200206000-00007","article-title":"Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes","volume":"21","author":"Oh","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.12.018_bib76","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/01.inf.0000053885.34703.84","article-title":"Palivizumab prophylaxis of respiratory syncytial virus disease from 1998\u20132002: results from four years of palivizumab usage","volume":"22","author":"Romero","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.12.018_bib77","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1442-200x.2005.02089.x","article-title":"Safety and efficacy of palivizumab prophylaxis in children with congenital heart disease","volume":"47","author":"Saji","year":"2005","journal-title":"Pediatr Int"},{"key":"10.1016\/j.anpedi.2009.12.018_bib78","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00006454-200011000-00007","article-title":"Effectiveness of palivizumab: evaluation of outcomes from the 1998\u20131999 respiratory syncytial virus season","volume":"19","author":"Sorrentino","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2009.12.018_bib79","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/jhin.2001.1002","article-title":"The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit","volume":"48","author":"Cox","year":"2001","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.anpedi.2009.12.018_bib80","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhin.2004.04.024","article-title":"Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit","volume":"58","author":"Abadesso","year":"2004","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.anpedi.2009.12.018_bib81","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/01.pec.0000278406.75815.d3","article-title":"Evaluation of compliance with palivizumab recommendations in a multicenter study of young children presenting to the emergency department with bronchiolitis","volume":"23","author":"Mansbach","year":"2007","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.anpedi.2009.12.018_bib82","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1378\/chest.128.4.2765","article-title":"Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: a national survey","volume":"128","author":"Prais","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.anpedi.2009.12.018_bib83","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3476(03)00213-0","article-title":"Respiratory syncytial virus (RSV) loads in premature infants with and without prophylactic RSV fusion protein monoclonal antibody","volume":"143","author":"DeVincenzo","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib84","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.clinthera.2004.12.005","article-title":"Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit?","volume":"26","author":"Geskey","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.anpedi.2009.12.018_bib85","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1695-4033(00)77494-7","article-title":"Antecedentes perinatales y hospitalizaci\u00f3n por bronquiolitis","volume":"53","author":"Bonillo Perales","year":"2000","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib86","first-page":"19","article-title":"Human metapneumovirus as hospitalization cause in children under 3 years old with acute respiratory infections during 2004","volume":"24","author":"Prado","year":"2007","journal-title":"Rev Chilena Infectol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib87","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1542\/peds.2006-2223","article-title":"Diagnosis and management of bronchiolitis","volume":"118","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.12.018_bib88","unstructured":"SIGN. Bronchiolitis in children. A national clinical guideline. Available at: http:\/\/www.sign.ac.uk. 2006."},{"key":"10.1016\/j.anpedi.2009.12.018_bib89","unstructured":"Bronchiolitis Guideline Team, Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for medical management of bronchiolitis in infants year of age or less presenting with a first time episode. Cincinnati: Cincinnati Children's Hospital Medical Center; 2005. [cited 22 August 2006]. Available from url: http:\/\/www.cincinnatichildrens.org\/NR\/rdonlyres\/0B7B99D7-DB3E-4186-B2FC-71539E23421E\/0\/bronchiolitisguideline.pdf"},{"key":"10.1016\/j.anpedi.2009.12.018_bib90","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/jp.2008.37","article-title":"Strategies for prevention of RSV nosocomial infection","volume":"28","author":"Groothuis","year":"2008","journal-title":"J Perinatol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib91","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/tropej\/48.2.118","article-title":"Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases","volume":"48","author":"Kilani","year":"2002","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.anpedi.2009.12.018_bib92","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.jp.7210696","article-title":"Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit","volume":"22","author":"Heerens","year":"2002","journal-title":"J Perinatol"},{"key":"10.1016\/j.anpedi.2009.12.018_bib93","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1542\/peds.104.6.e77","article-title":"Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants","volume":"104","author":"B\u00fclow","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2009.12.018_bib94","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/adc.2003.028282","article-title":"Lower respiratory tract illness and RSV prophylaxis in very premature infants","volume":"89","author":"Lacaze-Masmonteil","year":"2004","journal-title":"Arch Dis Child"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403310000858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403310000858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T10:08:51Z","timestamp":1532599731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403310000858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1695403310000858"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2009.12.018","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}